The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-d-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles

AAPS PharmSciTech

Volumn 13, Issue 4, 2012, Pages 1348-1354

  Wang, Mei ^a   Qin, Lili ^a   Li, Kun ^a   Zhu, Rongrong ^a   Wang, Wenrui ^a   Wang, Shilong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

benzoic acid, 2 hydroxy , 2 d ribofuranosylhydrazide (BHR); controlled release; drug delivery; solid lipid nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOIC ACID, 2 HYDROXY, 2 DEXTRO RIBOFURANOSYLHYDRAZIDE; NANOPARTICLE; SALICYLIC ACID DERIVATIVE; SOLID LIPID NANOPARTICLLE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CYTOTOXICITY; DRUG POTENCY; DRUG RELEASE; DRUG STABILITY; FEMALE; GEL CHROMATOGRAPHY; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; BENZOIC ACID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HEK293 CELLS; HELA CELLS; HUMANS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 84871666729     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9862-8     Document Type: Article

References (33)

1. Owen RW, Giacosa A, Hull WE, Haubnerelhalder B, Bartsch H. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer. 2000;36:1235-47.
2. Guilherme AS, Cristiane MF, Mauro SP, Patricia Z. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol. 2009;77:46-53.
3. Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem. 2008;16:9101-5.
4. Salzmann U, Ludwig P, Schewe I, Rapoport SM. The share of lipoxygenase in the antimycin-resistant oxygen uptake of rabbit reticulocytes. Biomed Biochim Acta. 1985;44:213-21.
5. Wang M, Cheng LL, Zhu H, Li K, Wu QS, Yao SD, et al. Characterization of the transient species generated in the photoexcitation of benzoic acid, 2-hydroxy, 2-d-ribofuranosylhydrazide. J Photochem Photobiol. 2009;208:104-9.
6. Zhu RR, Qin LL, Wang M, Wu SM, Wang SL, Zhang R, et al. Preparation, characterization and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology. 2009;20:055702. doi: 10.1088/0957-4484/20/5/ 055702.
7. Qin LL, Wang SL, Zhang R, Zhu RR, Sun XY, Yao SD. Two different approaches to synthesizing Mg-Al-layered double hydroxides as folic acid carriers. J Phys Chem Solids. 2008;69:2779-84.
8. Qin LL, Xue M, Wang WR, Zhu RR, Wang SL, Sun J, et al. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin. Int J Pharm. 2010;388:223-30.
9. Li A, Qin LL, Zhu D, Zhu RR, Sun J, Wang SL. Signaling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles. Biomaterials. 2010;31:748-56.
10. Li A, Qin LL, Wang WR, Zhu RR, Yu YC, Liu H, Wang SL. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials. 2011;32:469-77.
11. Xue YH, Zhang R, Sun XY, Wang SL. The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins. Mater Sci Mater Med. 2007;8:1197-202.
12. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci. 2006;61:1027-40.
13. 2 and trypsin inhibit the enzyme activity and change the secondary structure of trypsin. Biol Trace Elem Res. 2010;142:435-46.
14. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161-77.
15. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165-96.
16. Wissing SA, Muller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254:65-8.
17. Li YC, Dong L, Jia A, Chang XN, Xue H. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol. 2006;38:296-9.
18. Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie. 2006;61:375-86.
19. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131-55.
20. Liu J, Gong T, Wang C, Zhong Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007;340:153-62.
21. Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS Pharm Sci Tech. 2007;8:162-70.
22. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454-77.
23. Chen HB, Chang XL, Du DR, Liu W. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 2006;110:296-306.
24. Kim JH, Kim YS, Park K, Kang E, Lee S, Nam HY, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials. 2008;29:1920-30.
25. You J, Wan F, Cui FD, Sun Y, Du YZ, Hu FQ. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int J Pharm. 2007;343:270-6.
26. Dubesa A, Parrot-Lopeza H, Abdelwahed W. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm. 2003;55:279-82.
27. Garg A, Singh S. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids Surf B Biointerfaces. 2011;87:280-8.
28. Lin XL, Li XW, Zheng Yu L, Zhang QQ, Liu WC. Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids Surf, A Physicochem Eng Asp. 2007;311:106-11.
29. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49:6449-65.
30. Kang SI, Na K, Bae YH. Physicochemical characteristics and doxorubicin release behaviors of pH/temperature-sensitive polymeric nanoparticles. Colloids Surf, A Physicochem Eng Asp. 2003;231:103-12.
31. Liu L, Jin P, Cheng M, Zhang G, Zhang F. 5-Fluorouracil-loaded self-assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors. Chin J Chem Eng. 2006;14:377-82.
32. Robhash KS, Keon WK, Hoo-Kyun C. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 2009;37:508-13.
33. Martins S, Costa-Lima S, Carneiro T, Cordeiro-da-Silva A, Souto EB, Ferreira DC. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int J Pharm. 2012;430:216-27.